Stack explorer
Stacks
Combinations that come up again and again in online discussion. For each one: what each part is supposed to do, how strong the evidence is for that part, what users of that part reported, and what to watch out for.
No combination data exists. None of these stacks has been tested as a combination in humans, and the Reddit reads counted people per substance, not per stack. The user figures below are each component’s own reports. “Success rates” that circulate online for these stacks are not shown: we could not trace them to countable reports.
Showing 7 of 7 stacks
The Wolverine Stack
Stated purpose: Maximum healing and recovery · most popular in the source discussions
- C
BPC-157
Investigational gastric pentadecapeptide
What it’s used for: injury/tendon healing and gut repair (injected or oral). Evidence: preliminary human data.
FDA Not approved WADA Prohibited (S0)- User score
- Reports
- 21 people · men 45–60: 3
- Used it with other compounds
- 8 of 21 (38%)
- Stopped
- 1 of 21 (5%)
- D
TB-500
Investigational thymosin beta-4-derived heptapeptide
What it’s used for: injected TB-500 fragment for injury recovery. Evidence: preclinical only.
FDA Not approved WADA Prohibited (S2.3)- User score
- Reports
- 11 people · men 45–60: 0
- Used it with other compounds
- 9 of 11 (82%)
- Stopped
- 3 of 11 (27%)
Warnings
- None of the human trials in our evidence files tested this combination. Any benefit of combining is untested.
- Banned or likely banned in tested sport (WADA): BPC-157, TB-500.
- Not FDA-approved: BPC-157, TB-500. Unapproved products may be impure, mislabelled or contaminated.
- Little or no human evidence for the marketed use: TB-500 (grade D).
Users who mention the combination
“I didn't notice a difference with TB-500, and prefer only BPC-157. Took a few weeks.”
“BPC-157 + TB500 current results 40M. I started BPC-157 & TB500 7 days”
The Body Recomp Stack
Stated purpose: Muscle gain, fat loss, anti-aging
- C
CJC-1295
Long-acting growth hormone-releasing hormone analogue
What it’s used for: raising growth hormone for body composition, recovery and sleep. Evidence: preliminary human data.
FDA Not approved WADA Prohibited (S2.2.4)- User score
- Reports
- 12 people · men 45–60: 1
- Used it with other compounds
- 12 of 12 (100%)
- Stopped
- 1 of 12 (8%)
- C
Ipamorelin
Peptide ghrelin receptor agonist and growth hormone secretagogue
What it’s used for: raising growth hormone for sleep and body composition. Evidence: preliminary human data.
FDA Not approved WADA Prohibited (S2.2.4)- User score
- Reports
- 48 people · men 45–60: 2
- Used it with other compounds
- 47 of 48 (98%)
- Stopped
- 2 of 48 (4%)
Warnings
- None of the human trials in our evidence files tested this combination. Any benefit of combining is untested.
- Banned or likely banned in tested sport (WADA): CJC-1295, Ipamorelin.
- Not FDA-approved: CJC-1295, Ipamorelin. Unapproved products may be impure, mislabelled or contaminated.
- Safety update for CJC-1295: The FDA has linked CJC-1295 to serious side effects, including a racing heart and sudden drops in blood pressure, and a 2006 trial was stopped after a participant died of a heart attack (cause not established).
- Safety update for Ipamorelin: The FDA reports serious side effects when ipamorelin was given by drip after bowel surgery, including two deaths (cause not established), and there is no long-term safety data for injections under the skin.
- Two growth-hormone secretagogues together push the same hormone axis; there is no safety data on the combination.
The Cognitive Enhancement Stack
Stated purpose: Focus, mood, stress management
- C
Semax
Synthetic ACTH-derived heptapeptide; investigational nootropic
What it’s used for: nootropic / cognitive enhancement. Evidence: preliminary human data.
FDA Not approved WADA Not named- User score
- Reports
- 61 people · men 45–60: 0
- Used it with other compounds
- 13 of 61 (21%)
- Stopped
- 6 of 61 (10%)
- C
Selank
Synthetic tuftsin-derived heptapeptide; investigational anxiolytic
What it’s used for: anxiety relief. Evidence: preliminary human data.
FDA Not approved WADA Not named- User score
- Reports
- 11 people · men 45–60: 0
- Used it with other compounds
- 5 of 11 (45%)
- Stopped
- 0 of 11 (0%)
Warnings
- None of the human trials in our evidence files tested this combination. Any benefit of combining is untested.
- Not FDA-approved: Semax, Selank. Unapproved products may be impure, mislabelled or contaminated.
Users who mention the combination
“As the title says I felt extreme nausea 3 hours after my morning SubQ dose My bottles are doses at 5mg selank/semax And 10mg PE22”
The Complete Wellness Stack
Stated purpose: Healing, anti-aging, immune support
- C
BPC-157
Investigational gastric pentadecapeptide
What it’s used for: injury/tendon healing and gut repair (injected or oral). Evidence: preliminary human data.
FDA Not approved WADA Prohibited (S0)- User score
- Reports
- 21 people · men 45–60: 3
- Used it with other compounds
- 8 of 21 (38%)
- Stopped
- 1 of 21 (5%)
- C
GHK-Cu
Copper-binding tripeptide complex
What it’s used for: topical skin and hair cosmetic use (injectable 'systemic anti-ageing' has no human trials). Evidence: preliminary human data.
FDA Not approved WADA Not named- User score
- Reports
- 64 people · men 45–60: 1
- Used it with other compounds
- 22 of 64 (34%)
- Stopped
- 5 of 64 (8%)
- B
Thymosin alpha-1
thymic immunomodulatory peptide
What it’s used for: immune support / infection defence. Evidence: moderate human evidence.
FDA Not approved WADA Not named- User score
- too few reports (9)
- Reports
- 9 people · men 45–60: 0
- Used it with other compounds
- 1 of 9
- Stopped
- 3 of 9
Warnings
- None of the human trials in our evidence files tested this combination. Any benefit of combining is untested.
- Banned or likely banned in tested sport (WADA): BPC-157.
- Not FDA-approved: BPC-157, GHK-Cu, Thymosin alpha-1. Unapproved products may be impure, mislabelled or contaminated.
Pre-mixed blends and a trial-tested combination
KLOW and GLOW are sold as one vial holding several peptides. CagriSema (cagrilintide with semaglutide) is the one combination here that has been tested as a combination in randomized trials.
GLOW D for the blend
Single-vial blend of GHK-Cu, BPC-157 and TB-500. Full GLOW page →
- C
GHK-Cu
Copper-binding tripeptide complex
On its own: graded for topical skin and hair cosmetic use (injectable 'systemic anti-ageing' has no human trials). Evidence: preliminary human data.
FDA Not approved WADA Not named - C
BPC-157
Investigational gastric pentadecapeptide
On its own: graded for injury/tendon healing and gut repair (injected or oral). Evidence: preliminary human data.
FDA Not approved WADA Prohibited (S0) - D
TB-500
Investigational thymosin beta-4-derived heptapeptide
On its own: graded for injected TB-500 fragment for injury recovery. Evidence: preclinical only.
FDA Not approved WADA Prohibited (S2.3)
Warnings
- No human trial of the complete GLOW blend was found (grade D for the blend). A component's grade does not become the mixture's grade.
- One vial means one fixed ratio: the components cannot be dosed separately, and compatibility and stability of the mixture are not established.
- Banned or likely banned in tested sport (WADA): BPC-157, TB-500.
- Not FDA-approved: GHK-Cu, BPC-157, TB-500. Unapproved products may be impure, mislabelled or contaminated.
- Little or no human evidence for the marketed use: TB-500 (grade D).
KLOW D for the blend
Single-vial blend of GHK-Cu, BPC-157, TB-500 and KPV. Full KLOW page →
- C
GHK-Cu
Copper-binding tripeptide complex
On its own: graded for topical skin and hair cosmetic use (injectable 'systemic anti-ageing' has no human trials). Evidence: preliminary human data.
FDA Not approved WADA Not named - C
BPC-157
Investigational gastric pentadecapeptide
On its own: graded for injury/tendon healing and gut repair (injected or oral). Evidence: preliminary human data.
FDA Not approved WADA Prohibited (S0) - D
TB-500
Investigational thymosin beta-4-derived heptapeptide
On its own: graded for injected TB-500 fragment for injury recovery. Evidence: preclinical only.
FDA Not approved WADA Prohibited (S2.3) - D
KPV
Investigational alpha-MSH-derived anti-inflammatory tripeptide
On its own: graded for gut and skin anti-inflammatory use. Evidence: preclinical only.
FDA Not approved WADA Likely prohibited (S0)
Warnings
- No human trial of the complete KLOW blend was found (grade D for the blend). A component's grade does not become the mixture's grade.
- One vial means one fixed ratio: the components cannot be dosed separately, and compatibility and stability of the mixture are not established.
- Banned or likely banned in tested sport (WADA): BPC-157, TB-500, KPV.
- Not FDA-approved: GHK-Cu, BPC-157, TB-500, KPV. Unapproved products may be impure, mislabelled or contaminated.
- Little or no human evidence for the marketed use: TB-500 (grade D), KPV (grade D).
CagriSema B for the combination
Cagrilintide and semaglutide given together. Full Cagrilintide page →
- B
Cagrilintide
Investigational long-acting amylin analogue; CagriSema combines it with semaglutide
On its own: graded for weight management (alone and as CagriSema with semaglutide). Evidence: moderate human evidence.
FDA Not approved WADA Likely prohibited (S0) - A
Semaglutide
GLP-1 receptor agonist
On its own: graded for weight management and type 2 diabetes. Evidence: strong human evidence.
FDA Approved WADA Not prohibited
Warnings
- This combination has been tested in randomized trials, but it is not approved (FDA: not approved). Products sold online as this combination are not the trial product.
- Banned or likely banned in tested sport (WADA): Cagrilintide.
- Not FDA-approved: Cagrilintide. Unapproved products may be impure, mislabelled or contaminated.
- Safety update for Semaglutide: 9 Nov 2026: the FDA now requires a warning on all GLP-1 drugs, including semaglutide (Ozempic, Wegovy, Rybelsus), about NAION, a rare optic-nerve stroke that can cause vision loss.
User reports are anecdata, not evidence: self-selected, unverified, often combined with other compounds.